Master-Studium Health Technology Assessment

Anbieter:: UMIT - Priv. Univ. f. Gesundheitswissenschaften, Med. Informatik und Technik
Ort, Bundesland, Land:: Hall in Tirol, Tirol, Österreich
Typ:: Berufsbegleitend
Abschluss:: M.Sc.
Dauer:: 6 Semester

Dieses Bildungsangebot auf die Merkliste setzen

Das Programm

The Master Program in ”Health Technology Assessment, Evidence-based Healthcare and Decision Science” is the first international Master Program of this kind and part of the Continuing Education Program in Health Technology Assessment & Decision Sciences (HTADS) at the Institute of Public Health, Medical Decision Making and HTA at UMIT. This program was designed to provide high quality education and comprehensive training on key issues within three important disciplines for those pursuing careers in the health sector. It covers three primary areas that inform medical and policy decisions in healthcare:

Health Technology Assessment,
Evidence-based Healthcare, and
Decision Science.

Christa Ramnek

Schwerpunkte / Curriculum

The Program has a modular curriculum. All modules combine lectures, discussions, case study group work, and hands-on computer lab sessions. Aside from the scientific and methodological focus of the program, students will be encouraged to translate their theoretical knowledge into practice by focused trainings and applied exercises. The faculty consists of leading international experts from universities, industry, and HTA agencies and representatives from other relevant areas who have committed to providing outstanding instruction in state-of-the-art principles.

The following modules are covered in the Master Program:
HTA Principles, Methods I & Practice; Biostatistics I; Clinical Epidemiology & Public Health; Literature Search, Systematic Review & Meta-Analysis I; Economic Evaluation in Health Care; Decision Science & Modeling I; HTA Methods II & Specific Aspects; Health Outcomes, Quality of Life & Patient-Reported Outcomes; Health Policy Management, Healthcare Systems, Reimbursement & Country-Specific HTA; Biostatistics & Epidemiology II; Meta-Analysis II; Decision Science & Modeling II; Scientific Writing & Skill Training.

A specific characteristic of the program is its special focus on quantitative methods and unique training in decision sciences as well as the combination of theoretical and applied case examples presented by professionals in the field.

Aufnahme und Zugangsvoraussetzungen
Berufsbegleitend:
Studienplätze:	k.A.
Bewerber:	k.A.

Gesamtkosten ca.:	€ 14.400,-

Admission to the Master degree program requires the successful completion of a university program (at least a bachelor degree level) in the field of medicine, public health, health sciences, epidemiology, statistics, pharmacy or related fields, provided that it has a significant focus on healthcare or sufficient relevant professional experience OR the successful completion of a post-secondary training program of a minimum duration of six semesters and sufficient relevant professional experience, or a diploma in a related field AND a good command of written and spoken English language.

Sprachen
Unterrichtssprache:	Englisch
Auslandsaufenthalt:	möglich

Career Prospects

Professional opportunities for the graduates of the Masters Program are available in different organizations within the health care sector including HTA institutions, federal ministries, health insurance programs, hospitals, pharmaceutical and medical device companies, public health services, universities, continuing education institutions, and contract research and consultancy organisations.

Infomaterial zu diesem Programm

Anrede:

Titel im passenden Namensfeld eintragen.

Vorname:

Name:

Strasse:

Plz/Ort:

Land:

Telefon:

e-Mail:

Ich will: Informationsmaterial

Rückruf

Sonstiges:

Der Anbieter

The Faculty of the Master Program is drawn from leading international experts from univeristies, industry and HTA agencies and representatives from other relevant areas who committed to provide teaching of state-of-the-art principles. Detailed information regarding faculty members will be available soon.

Uwe Siebert, MD, MPH, MSc, ScD

Prof. Uwe Siebert, MD, MPH, MSc, ScD, Professor of Public Health, is the Director of the Institute of Public Health, Medical Decision Making and Health Technology Assessment at the University of Health Sciences, Medical Informatics and Technology (UMIT) in Austria. He is also Adjunct Professor of Health Policy and Management at the Harvard School of Public Health and Associate Professor of Radiology at Harvard Medical School, where he directs the Program on Cardiovascular Research at the Institute for Technology Assessment, Massachusetts General Hospital, Boston. He has an adjunct teaching appointment at the School of Public Health and Epidemiology at the University of Munich.

After medical school, Prof. Siebert worked for several years as a physician in international public health projects. He then earned an MPH at the Munich School of Public Health, and completed an MSc in Epidemiology and an ScD in Health Policy and Management with a concentration in decision sciences at the Harvard School of Public Health. Before he started his faculty position at Harvard Medical School, he was the Director of the Bavarian Public Health Research and Coordinating Center at the University of Munich, Germany, and completed Visiting Scholarship at the Harvard Center for Risk Analysis.

His research interests include applying decision-analytic modeling, meta-analysis, quality-of-life assessment and cost-effectiveness analysis in the framework of health technology assessments (HTA) as well as in the clinical context of routine health care. His current substantive research focuses on cancer, cardiovascular disease, diabetes, hepatitis C, HIV, and neurological disorders. His methodological research is focused on evaluations of public health interventions, prevention and screening, diagnostic imaging procedures, personalized medicine as well as the development of causal decision models based on complex longitudinal data with time-varying interventions or exposures.

Prof. Siebert is a member of the Board of Trustees of the Society of Medical Decision Making (SMDM), a member of the International Expert Committee Advising the Institute for Quality and Efficiency in Health Care (IQWiG) on the Methods for Economic Evaluations of Health Care Interventions, a member of the Advisory Board of the Ludwig Boltzmann Institute for Health Technology Assessment in Austria, and he has served as a member of the Board of Directors of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He is member of the Steering Committee of ONCOTYROL - Center of Personalized Cancer Medicine in Austria and Director of the Division for Public Health Decision Modeling, HTA and Health Economics in the Center. He is the Chairman of the Working Groups "Health Economics" and "Medical Decision Making" of the German Society for Medical Informatics, Biometry and Epidemiology (GMDS). He is Co-Chair of the "Issues in Methodology Section" of the SMDM Policy Initiative. He teaches courses in decision analysis, HTA, economic evaluation, and advanced epidemiologic methods at several universities and for industry in Europe and the US. He advises government agencies, academic institutions and the industry regarding the conduction and impact of health technology assessments on policy and reimbursement decisions. He has authored more than 150 publications including HTA reports, textbook chapters for decision analysis, scientific articles, and editorials.

Studieren in Hall in Tirol

Die geschmackvollen Bauten der Haller Altstadt zeugen von der Vergangenheit als wohlhabende Stadt: Hall wurde im Mittelalter durch die Salzgewinnung zum bedeutendsten Wirtschaftsplatz Nordtirols. Die Stadt war bereits im Mittelalter ein wichtiger Warenumschlagsplatz für den Handel auf dem Inn, die landesfürstliche Münzstätte, die ab Mitte des 15. Jahrhunderts in Hall angesiedelt war, trug wesentlich zum weiteren wirtschaftlichen Aufschwung bei.

Heute ist Hall eine pulsierende Kleinstadt voller Lebensfreude, in der man abwechslungsreiche Einkaufsmöglichkeiten und stilvolle Gastlichkeit zwischen geschichtsträchtigen Mauern erleben kann. Die liebevoll restaurierte Haller Altstadt und das Areal der Burg Hasegg mit dem Münzerturm und angeschlossenen Münzmuseum ziehen jedes Jahr Besucher aus aller Herren Länder in ihren Bann.

Studienberatung und Information

Christa Ramnek

050 8648-3837

lehre@umit.at

UMIT - Priv. Univ. f. Gesundheitswissenschaften, Med. Informatik und Technik
Department für Public Health & HTA
Eduard Wallnöfer-Zentrum 1
6060 Hall in Tirol
Österreich

+43 (0)50 8648-3000

+43 (0)50 8648-673001

service@umit.at

www.umit.at

Anfahrt / Lageplan

Dieses Bildungsangebot
auf die Merkliste setzen